Back to Stakeholders

Hospitals Independent Academic Research Groups

Centre Hospitalier Universitaire de Charleroi

Belgium

6 Trials

University hospital in Charleroi, Belgium affiliated with the Université Libre de Bruxelles. Participates in clinical trials for psychiatric and neurological conditions, including studies in the emerging area of esketamine and rapid-acting antidepressant therapies.

Quick Facts

Type: Other
HQ: Belgium
Website: Visit

Sponsored Trials

4

Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression (PSILODAC)

Start Date: November 19, 2024
Compounds: Psilocybin

Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients with Psychogenic Nonepileptic Seizures (CRIPSY)

Start Date: November 1, 2024
Compounds: Psilocybin

Psilocybin in Alcohol Use Disorder With Comorbid Depression (PAD)

Start Date: January 1, 2024
Compounds: Psilocybin

Unknown statusNA

Comparison of Ketamine and Esketamine in Patients Suffering From Fibromyalgia Syndrome

Start Date: July 1, 2021
Compounds: Ketamine, Esketamine

Collaborated Trials

2

RecruitingII, III

Ketamine to Treat Patients With Post-comatose Disorders of Consciousness

Start Date: May 1, 2022
Compounds: Ketamine, Placebo

RecruitingI, II

Psilocybin for Psychological and Existential Distress in Palliative Care

Start Date: August 1, 2021
Compounds: Psilocybin